167 related articles for article (PubMed ID: 9398202)
1. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
Ohndorf UM; Whitehead JP; Raju NL; Lippard SJ
Biochemistry; 1997 Dec; 36(48):14807-15. PubMed ID: 9398202
[TBL] [Abstract][Full Text] [Related]
2. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
[TBL] [Abstract][Full Text] [Related]
3. Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo.
McA'Nulty MM; Whitehead JP; Lippard SJ
Biochemistry; 1996 May; 35(19):6089-99. PubMed ID: 8634251
[TBL] [Abstract][Full Text] [Related]
4. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
[TBL] [Abstract][Full Text] [Related]
5. DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA.
Dunham SU; Lippard SJ
Biochemistry; 1997 Sep; 36(38):11428-36. PubMed ID: 9298962
[TBL] [Abstract][Full Text] [Related]
6. Nature of full-length HMGB1 binding to cisplatin-modified DNA.
Jung Y; Lippard SJ
Biochemistry; 2003 Mar; 42(9):2664-71. PubMed ID: 12614161
[TBL] [Abstract][Full Text] [Related]
7. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct.
Chow CS; Barnes CM; Lippard SJ
Biochemistry; 1995 Mar; 34(9):2956-64. PubMed ID: 7893709
[TBL] [Abstract][Full Text] [Related]
8. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.
Kane SA; Lippard SJ
Biochemistry; 1996 Feb; 35(7):2180-8. PubMed ID: 8652559
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
Zhai X; Beckmann H; Jantzen HM; Essigmann JM
Biochemistry; 1998 Nov; 37(46):16307-15. PubMed ID: 9819223
[TBL] [Abstract][Full Text] [Related]
10. Interaction between cisplatin-modified DNA and the HMG boxes of HMG 1: DNase I footprinting and circular dichroism.
Locker D; Decoville M; Maurizot JC; Bianchi ME; Leng M
J Mol Biol; 1995 Feb; 246(2):243-7. PubMed ID: 7869375
[TBL] [Abstract][Full Text] [Related]
11. LEF-1 recognition of platinated GG sequences within double-stranded DNA. Influence of flanking bases.
Chválová K; Sari MA; Bombard S; Kozelka J
J Inorg Biochem; 2008 Feb; 102(2):242-50. PubMed ID: 17961652
[TBL] [Abstract][Full Text] [Related]
12. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA.
Pilch DS; Dunham SU; Jamieson ER; Lippard SJ; Breslauer KJ
J Mol Biol; 2000 Feb; 296(3):803-12. PubMed ID: 10677282
[TBL] [Abstract][Full Text] [Related]
13. Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro.
Patrick SM; Turchi JJ
Biochemistry; 1998 Jun; 37(24):8808-15. PubMed ID: 9628743
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-DNA binding specificity of calf high-mobility group 1 protein.
Turchi JJ; Li M; Henkels KM
Biochemistry; 1996 Mar; 35(9):2992-3000. PubMed ID: 8608137
[TBL] [Abstract][Full Text] [Related]
15. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
Kasparkova J; Delalande O; Stros M; Elizondo-Riojas MA; Vojtiskova M; Kozelka J; Brabec V
Biochemistry; 2003 Feb; 42(5):1234-44. PubMed ID: 12564926
[TBL] [Abstract][Full Text] [Related]
16. Recognition and repair of DNA-cisplatin adducts.
Woźniak K; Błasiak J
Acta Biochim Pol; 2002; 49(3):583-96. PubMed ID: 12422229
[TBL] [Abstract][Full Text] [Related]
17. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.
Cohen SM; Mikata Y; He Q; Lippard SJ
Biochemistry; 2000 Sep; 39(38):11771-6. PubMed ID: 10995245
[TBL] [Abstract][Full Text] [Related]
18. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
Vaisman A; Lim SE; Patrick SM; Copeland WC; Hinkle DC; Turchi JJ; Chaney SG
Biochemistry; 1999 Aug; 38(34):11026-39. PubMed ID: 10460158
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.
Takahara PM; Rosenzweig AC; Frederick CA; Lippard SJ
Nature; 1995 Oct; 377(6550):649-52. PubMed ID: 7566180
[TBL] [Abstract][Full Text] [Related]
20. Recognition of platinum-induced DNA damage by nuclear proteins: screening for mechanisms.
Marples B; Adomat H; Billings PC; Farrell NP; Koch CJ; Skov KA
Anticancer Drug Des; 1994 Oct; 9(5):389-99. PubMed ID: 7945723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
